News Daily News Top Policy and Practice News for Cardiologists in 2023 Caitlin E. Cox December 20, 2023
News Daily News Diagnosing FH in Kids and Teens Should Happen Early: In Real Life, It Varies Michael O'Riordan December 19, 2023
News Daily News Family History of CVD? Low PUFA Intake May Add to Risk Michael O'Riordan December 12, 2023
News Daily News Bempedoic Acid Reassures in Patients With and Without Diabetes: CLEAR Outcomes Michael O'Riordan December 08, 2023
News Conference News AHA 2023 AI Improves Detection of Cardiomyopathy in Pregnancy L.A. McKeown November 15, 2023
News Conference News AHA 2023 Large, Sustained Reductions in Lp(a) With Lepodisiran in Phase I Study Michael O'Riordan November 13, 2023
News Conference News AHA 2023 Gene Editing Shuts Off PCSK9 to Lower LDL in HeFH Caitlin E. Cox November 12, 2023
News Daily News Younger Age at AF Onset Linked to Greater Dementia Risk Yael L. Maxwell November 10, 2023
News Daily News Guiding DAPT Based on Genes or Platelet Tests Still ‘Tempting’ Yael L. Maxwell November 08, 2023
News Daily News Evinacumab Helps Severe Hypercholesterolemia Patients Reach LDL Targets Michael O'Riordan September 14, 2023
News Daily News Unguided De-escalation, Short DAPT the Best Strategies in ACS: Meta-analysis Yael L. Maxwell September 05, 2023
News Conference News ESC 2023 ESC Cardiomyopathy Guidelines Span Range of Phenotypes Yael L. Maxwell August 31, 2023
News Conference News ESC 2023 New Lancet Commission Takes Aim at Sudden Cardiac Deaths Yael L. Maxwell August 29, 2023
News Daily News ‘All of Us’ Research Program’s Diversity Is Off to a Good Start, Data Suggest Caitlin E. Cox August 21, 2023
News Daily News Acute MI Patients Without Standard CVD Risk Factors at Higher Risk of Death Michael O'Riordan July 07, 2023
News Daily News US Athlete’s Death Highlights Risk of Hypertensive Disorders of Pregnancy Michael O'Riordan June 19, 2023
News Conference News EAS 2023 Multipronged Outreach to Families Can Boost FH Cascade Screening: IMPACT-FH Michael O'Riordan May 26, 2023
News Conference News EAS 2023 Variable Response to Novel PCSK9 Inhibitor Lerodalcibep in LIBERATE-HoFH Michael O'Riordan May 24, 2023